🔎 Trials Near Me

Akèy › Kansè nan tete › Kalifòni › Torrance

Etid klinik pou Kansè nan tete nan Torrance, CA

9 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Torrance (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Ap rekriteFaz 3
  • Torrance Memorial Physician Network- Cancer Care, Torrance
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06492616

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Ap rekriteFaz 3
  • Torrance Memorial Cancer Center, Torrance
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06072612

Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

Ap rekriteFaz 1 bonè
  • CS Cancer at the Hunt Cancer Center, Torrance
Laj 18 ak plis · Fanm · Mizajou Aug 4, 2026 · NCT06123286

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • Torrance Memorial Physician Network - Cancer Care, Torrance
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Ap rekriteEtid obsèvasyon
  • Harbor-UCLA Medical Center - Hematology / Oncology, Torrance
Laj 18 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT06401421

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Ap rekriteFaz 2
  • Torrance Memorial Physician Network / Cancer Care, Torrance
Laj 18 ak plis · Tout sèks · Mizajou Nov 10, 2025 · NCT04553770

Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer

Ap rekriteFaz 2
  • City of Hope at South Bay, Torrance
Laj 40 ak plis · Fanm · Mizajou Oct 29, 2025 · NCT06954831

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Ap rekriteFaz 3
  • City of Hope South Bay, Torrance
Laj 18 ak plis · Tout sèks · Mizajou Oct 8, 2025 · NCT03418961

Etid Kansè nan tete nan lòt vil

Lòt etid nan Torrance

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.